Brief: Real-World Evidence Confirms Idgenetix®-Guided Medication Management Significantly Improves Response And Remission Rates In Patients With Major Depressive Disorder
08/11/2023 23:11
Nov 8 (Reuters) - Castle Biosciences Inc CSTL.O :
* REAL-WORLD EVIDENCE CONFIRMS IDGENETIX®-GUIDED MEDICATION
MANAGEMENT SIGNIFICANTLY IMPROVES RESPONSE AND REMISSION RATES
IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER
Source text for Eikon: ID:nBwQ2VbGa
Further company coverage: CSTL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Castle Biosciences
See all newsBrief: Castle Biosciences, - Opens New Laboratory And Office Facility In Scottsdale, Arizona
U.S. RESEARCH ROUNDUP-Abbvie, Amazon, Illumina
Castle Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Castle Biosciences beats Q2 revenue estimates, hikes forecast
Brief: Castle Biosciences Q2 Revenue USD 103.546 Million Vs. IBES Estimate USD 86.2 Million